BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19414351)

  • 1. Oestrogen-synthesising enzymes and breast cancer.
    Kulendran M; Salhab M; Mokbel K
    Anticancer Res; 2009 Apr; 29(4):1095-109. PubMed ID: 19414351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen producing enzymes and mammary carcinogenesis: a review.
    Subramanian A; Salhab M; Mokbel K
    Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
    Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
    Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
    Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
    Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
    Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
    J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
    Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
    Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ production of estrogens in human breast carcinoma.
    Suzuki T; Moriya T; Ishida T; Kimura M; Ohuchi N; Sasano H
    Breast Cancer; 2002; 9(4):296-302. PubMed ID: 12459709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
    Aka JA; Mazumdar M; Lin SX
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):183-90. PubMed ID: 19038308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
    Geisler J; Sasano H; Chen S; Purohit A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):39-45. PubMed ID: 21356310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracrine mechanism of estrogen synthesis in breast cancer.
    Suzuki T; Moriya T; Ishida T; Ohuchi N; Sasano H
    Biomed Pharmacother; 2003 Dec; 57(10):460-2. PubMed ID: 14637389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
    Fournier MA; Poirier D
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase and the breast: regulation and clinical aspects.
    Miller WR
    Maturitas; 2006 Jul; 54(4):335-41. PubMed ID: 16730141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
    Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid sulfatase inhibitors: promising new therapy for breast cancer.
    Sadozai H
    J Pak Med Assoc; 2013 Apr; 63(4):509-15. PubMed ID: 23905452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steroid sulfatase inhibitor].
    Nakata T; Ishida H; Shiotsu Y
    Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity of steroidal estrogens.
    Russo J; Russo IH
    Trends Endocrinol Metab; 2004 Jul; 15(5):211-4. PubMed ID: 15223050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
    Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
    Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.